← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Jyant, Inc.
Marietta, GA
$1,184,651
Total funding
4
Grants
Funding over time
peak $540.3K · FY2013–17$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$1,184,651 · 4
By mechanism
R41$890,320 · 3
R43$294,331 · 1
Investigators at Jyant, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Anti-CCL25 mAb to treat castration resistant prostate cancer$350,000
R41 · FY2017 · CA
Anti-CXCL13 mAb to mitigate prostate cancer health disparities$315,320
R41 · FY2015 · MD
Novel adjuvant therapy for triple negative breast cancer$225,000
R41 · FY2015 · CA
Treatment of Colitis using a Novel CXCR3 Biologic Antagonist$197,171
R43 · FY2013 · DK
Treatment of Colitis using a Novel CXCR3 Biologic Antagonist$97,160
R43 · FY2014 · DK